Shiro Kohi

977 citations
35 papers · 743 indexed · h-index 15
Topics
Proteoglycans and glycosaminoglycans research (17 papers)Fibroblast Growth Factor Research (11 papers)Glycosylation and Glycoproteins Research (10 papers)
Partner nations
JapanChinaUnited States

In The Last Decade

Shiro Kohi

31 papers receiving 735 citations

Peers

Shiro Kohi
Comparison fields: 5 of 64
  • Molecular Biology 406
  • Oncology 403
  • Cell Biology 260
  • Cancer Research 166
  • Surgery 103
Replace Sihem Khelifa with:
Sihem Khelifa United States
Reeti Behera United States
Kei Matsuda United States
Alexandra Fullár Hungary
Sirirat Takahashi Japan
Heungnam Kim United States
Ugo Ekeowa United Kingdom
Sander P.J. Joosten Netherlands
Shiro Kohi relative to Sihem Khelifa United States Sihem Khelifa's profile →
Citations per field
00.5×
Sihem Khelifa · 1×
Citations per year

Countries citing papers authored by Shiro Kohi

Since Specialization
Citations

This map shows the geographic impact of Shiro Kohi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Kohi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Kohi more than expected).

Fields of papers citing papers by Shiro Kohi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiro Kohi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Kohi. The network helps show where Shiro Kohi may publish in the future.

Co-authorship network of co-authors of Shiro Kohi

This figure shows the co-authorship network connecting the top 25 collaborators of Shiro Kohi. A scholar is included among the top collaborators of Shiro Kohi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiro Kohi. Shiro Kohi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 0
4 9
5 1
6 4
7 13
8 7
9 15
10 16
11 38
12 19
13 54
14 58
15 7
16 22
17 36
18 0
19
A Case of Laparoscopic Sigmoid Colon Cancer Resection with Horseshoe Kidney
1
20
0

About Shiro Kohi

Shiro Kohi is a scholar working on Cell Biology, Oncology and Surgery, having authored 35 papers that have together received 743 indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (17 papers), Fibroblast Growth Factor Research (11 papers) and Glycosylation and Glycoproteins Research (10 papers). The work is most often cited by research in Cell Biology (260 citations), Oncology (403 citations) and Cancer Research (166 citations). Shiro Kohi has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Norihiro Sato, Keiji Hirata, Xiaobo Cheng, Atsuhiro Koga, Michael Goggins, Koji Yamaguchi, Michael Borges, Toshiya Abe, Mohamad Dbouk and Anne M. Macgregor‐Das. Their work appears in journals such as PLoS ONE, Scientific Reports and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026